Calithera Biosciences Inc expected to post a loss of 28  cents a share - Earnings Preview

Calithera Biosciences

05/05/2021 03:00

* Calithera Biosciences Inc  CALA.OQ   CALA.O  is expected to
show a no change in quarterly revenue when it reports results on
May 6.
​* Refinitiv's mean analyst estimate for Calithera Biosciences
Inc is for a loss of 28 cents per share. For the same quarter
last year, the company reported a loss of 38 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Calithera
Biosciences Inc is $4​, about 48.5% above​ its last closing
price of $2.06. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.33       -0.32      -0.32     Met     1.2
 Sep. 30 2020  -0.31       -0.31      -0.32     Missed  -3.1
 Jun. 30 2020  -0.33       -0.33      -0.29     Beat    13.3​
 Mar. 31 2020  -0.36       -0.36      -0.38     Missed  -5.8
 Dec.          -0.39​      -0.37      -0.39     Missed  -4.7​
 31​ 2019​                                              
 Sep. 30 2019  -0.48       -0.45      -0.38     Beat    14.9​
 Jun. 30 2019  -0.60       -0.56      -0.58     Missed  -4.4
 Mar. 31 2019  -0.46       -0.44      -0.61     Missed  -37.2
 This summary was machine generated May 5 at 02:00 GMT.  All
figures in US dollars unless otherwise stated